C00-C14 C15 C16 C25 C34 C32 C30 C31 C81 C82 C83 C84 C85
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Oncological disease with diagnosis of (stages 1-4): -pancreatic carcinoma, -Bronchial carcinoma, -ent caricnoma -esophageal carcinoma -stomach carcinoma -malignant lymphomas - Metastatic or non-metastatic - No cachexia or cachexia with 5% weight loss in the last 6 months - Neo-adjuvant or adjuvant systemic therapy (chemo- or immunotherapy) and/or radiotherapy - 10 weeks after cancer diagnosis
Exclusion criteria
Exclusion criteria: -only surgery or only radiotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight and bmi T1 12 weeks post- testing T2 12 weeks follow up T3 52 weeks follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional testing - Muscle strength of upper extremities (HandGrip test) - Endurance performance (bicycle ergometer 30/15 test [Spiro]) - Body composition (bio-impedance analysis, mobile device: DataInput) - Power hand grip, leg press (Isokinet) Questionnaire - FAACT (Cachexia) - Subjective physical activity level (BSA) - Quality of Life (EORTC QLQ C30) - Fatigue (MFI20) -HADS blood count, albumin, total protein, CRP, CK | — |
Countries
Germany
Contacts
Uniklinik Köln